REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 21st, 2020 • Deerfield Healthcare Technology Acquisitions Corp. • Blank checks • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 16, 2020, is made and entered into by and among Deerfield Healthcare Technology Acquisitions Corp., a Delaware corporation (the “Company”), DFHTA Sponsor LLC, a Delaware limited liability company (the “Sponsor”) and the undersigned parties listed on the signature page hereto under “Holders” (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively the “Holders”).
INVESTMENT MANAGEMENT TRUST AGREEMENTInvestment Management Trust Agreement • July 21st, 2020 • Deerfield Healthcare Technology Acquisitions Corp. • Blank checks • New York
This Investment Management Trust Agreement (this “Agreement”) is made effective as of July 16, 2020 by and between Deerfield Healthcare Technology Acquisitions Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).
Deerfield Healthcare Technology Acquisitions Corp.Letter Agreement • July 21st, 2020 • Deerfield Healthcare Technology Acquisitions Corp. • Blank checks • New York
This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among Deerfield Healthcare Technology Acquisitions Corp., a Delaware corporation (the “Company”), and Deutsche Bank Securities Inc. as representative (the “Representative”) of the several underwriters (each, an “Underwriter” and collectively, the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”), of up to 14,375,000 of the Company’s units (including up to 1,875,000 units that may be purchased to cover over-allotments, if any) (the “Units”), each comprised of one share of the Company’s Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), and one-fifth of one redeemable warrant. Each whole warrant (each, a “Warrant”) entitles the holder thereof to purchase one share of Class A Common Stock at a price of $11.50 per share, subject to adjustment as described in th
WARRANT AGREEMENTWarrant Agreement • July 21st, 2020 • Deerfield Healthcare Technology Acquisitions Corp. • Blank checks • New York
THIS WARRANT AGREEMENT (this “Agreement”), dated as of July 16, 2020, is by and between Deerfield Healthcare Technology Acquisitions Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”, and also referred to herein as the “Transfer Agent”).
PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENTPrivate Placement Warrants Purchase Agreement • July 21st, 2020 • Deerfield Healthcare Technology Acquisitions Corp. • Blank checks • New York
THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of July 16, 2020 (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), is entered into by and among Deerfield Healthcare Technology Acquisitions Corp., a Delaware corporation (the “Company”), and DFHTA Sponsor LLC, a Delaware limited liability company (the “Purchaser”).
Deerfield Healthcare Technology Acquisitions Corp. 12,500,000 Units Underwriting AgreementUnderwriting Agreement • July 21st, 2020 • Deerfield Healthcare Technology Acquisitions Corp. • Blank checks • New York
Deerfield Healthcare Technology Acquisitions Corp., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (collectively, the “Underwriters”) an aggregate of 12,500,000 units (the “Firm Units”) of the Company and, at the election of the Underwriters, up to 1,875,000 additional units, if any (the “Optional Units”, the Optional Units, together with the Firm Units, that the Underwriters elect to purchase pursuant to Section 2 hereof being hereinafter called the “Units”).
STRATEGIC SERVICES AGREEMENTStrategic Services Agreement • July 21st, 2020 • Deerfield Healthcare Technology Acquisitions Corp. • Blank checks • Delaware
This Agreement is made on this 16th day of July, 2020 by and between Deerfield Healthcare Technology Acquisitions Corp., a Delaware corporation (the “Company”), and Christopher Wolfe (the “Strategic Consultant”) The Company and Strategic Consultant are sometimes hereinafter referred to singly as the “Party” and collectively as the “Parties.”
Deerfield Healthcare Technology Acquisitions Corp. New York, NY 10017 Re: Deerfield Agreement Gentlemen:Letter Agreement • July 21st, 2020 • Deerfield Healthcare Technology Acquisitions Corp. • Blank checks • New York
This letter (this “Letter Agreement”) is being executed and delivered in connection with the proposed underwritten initial public offering (the “Public Offering”) by Deerfield Healthcare Technology Acquisitions Corp., a Delaware corporation (the “Company”) of units (the “Units”). The Units shall be sold in the Public Offering pursuant to a registration statement on Form S-1 and prospectus (the “Prospectus”) filed by the Company with the U.S. Securities and Exchange Commission (the “Commission”) and the Company has applied to have the Units listed on The Nasdaq Capital Market.
DEERFIELD HEALTHCARE TECHNOLOGY ACQUISITIONS CORP. New York, NY 10017Letter Agreement • July 21st, 2020 • Deerfield Healthcare Technology Acquisitions Corp. • Blank checks • New York
This letter agreement (this “Agreement”) by and among Deerfield Healthcare Technology Acquisitions Corp. (the “Company”) and DFHTA Sponsor LLC (the “Sponsor”), dated as of the date hereof, will confirm our agreement that, commencing on the date the securities of the Company are first listed on The Nasdaq Capital Market (the “Listing Date”), pursuant to a Registration Statement on Form S-1 and prospectus filed with the U.S. Securities and Exchange Commission (the “Registration Statement”) and continuing until the earlier of the consummation by the Company of an initial business combination or the Company’s liquidation (in each case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”):
